Recent advances in type 2 diabetes (T2D) research have highlighted the benefits of sodium‐
glucose co‐transporter‐2 (SGLT‐2) inhibitors, including cardiovascular and renal protection …

Over recent years, the expanding evidence base for sodium-glucose cotransporter-2
inhibitor (SGLT2i) therapies has revealed benefits beyond their glucose-lowering efficacy in …

Purpose: No evidence exists as to whether type 2 diabetes mellitus (T2DM) impairs clinical
outcome from immune checkpoint inhibitors (ICI) in patients with solid tumors. Experimental …

A gender-specific drug utilization study was performed in the Campania region, Southern
Italy. Data were based on outpatient drug prescriptions collected from administrative …

Medication adherence is a priority for health systems worldwide and is widely recognised as
a key component of quality of care for disease management. Adherence-related indicators …

Objectives: Little is known about the specific comorbidities contributing to higher costs in
patients with type-2 diabetes mellitus (T2DM), particularly in older cases. We aimed to …

Background The novel coronavirus (SARS-CoV-2) pandemic spread rapidly worldwide
increasing exponentially in Italy. To date, there is lack of studies describing clinical …

Objectives Prophylactic drugs currently used for migraine treatment are not specific.
Furthermore, few studies in existing literature describe drugs utilisation patterns and …

Abstract Coronavirus disease 2019 (COVID-19) has substantially challenged healthcare
systems worldwide. By investigating population characteristics and prescribing profiles, it is …

Background and objectives: In the last couple of years, pharmacological management of
patients with type 2 diabetes mellitus (T2DM) have been markedly renewed. The aim of this …